Pulmonary Langerhans cell histiocytosis

Disease description

A group of disorders resulting from the abnormal proliferation of and tissue infiltration by LANGERHANS CELLS which can be detected by their characteristic Birbeck granules (X bodies), or by monoclonal antibody staining for their surface CD1 ANTIGENS. Langerhans-cell granulomatosis can involve a single organ, or can be a systemic disorder. Year introduced: 1990(1975)

Source: MeSH

References 1

Download references

with link to reference page

Journal Year Authors
Separating smoking-related diseases using NMR-based metabolomics of exhaled breath condensate. J. Proteome Res. 2013 G. de Laurentiis, D. Paris, D. Melck, P. Montuschi, M. Maniscalco, A. Bianco, M. Sofia, A. Motta
J. Proteome Res. 2013 Mar;12(3):1502-11. PubMed:23360153

Compounds 7

Download compounds
Acetate PubChem CID: 175
Ethanol PubChem CID: 702
1-methylimidazole PubChem CID: 1390
Isopropanol PubChem CID: 3776
Isobutyric acid PubChem CID: 6590
Propanoate PubChem CID: 104745
Methanol PubChem CID: 101954077

MeSH information

MeSH ID D006646
MeSH name Histiocytosis, Langerhans-Cell